Check out which companies are making headlines in pre-market trading. Robinhood – Shares of the brokerage firm jumped more than 6% after unveiling the Robinhood Gold Card, a credit card through which cash can be deposited into a brokerage account. Concentrix – Shares fell nearly 4% on disappointing fiscal second-quarter earnings guidance. The customer experience technology company also reiterated its full-year outlook for 2024. GameStop – Shares fell more than 17% after the video game retailer reported a significant drop in revenue in the fourth quarter compared to the same period a year earlier. The company added that it has also reduced its workforce by an unspecified number across the quartet to cut costs. Moderna – Shares rose 3.5% after the drug company said it has advanced three vaccines into final-stage trials. Separately, Blackstone Lifesciences said it would provide up to $750 million in funding for Moderna's influenza program. nCino – The cloud software company gained nearly 12% after the company reported a 13% revenue increase in the first quarter compared to the previous year. The company's fourth-quarter profits also exceeded analysts' expectations. Krispy Kreme – Shares rose more than 2%, adding to their rise of 39% from the previous session. The company announced Tuesday that it will expand its partnership with McDonald's to sell donuts at the fast-food chain's restaurants, with nationwide availability estimated by 2026. Viking Therapeutics — Shares rose nearly 3%. In the previous session, the stock rose more than 15% after promising trial results for weight loss pills. Deutsche Bank – Shares rose 3% after an upgrade to overweight from Morgan Stanley. The company said the German bank may have more room to run despite strong gains in 2024. Trump Media and Technology Group — Shares of former President Donald Trump's social media company rose nearly 14% after it debuted as a publicly traded company the day before. . . Merck — Shares posted a nearly 5% gain after the Food and Drug Administration approved Merck's life-threatening lung condition treatment, Winrevair, for use among adults with pulmonary arterial hypertension. Carnival – Shares added 2% ahead of the cruise operator's first-quarter earnings report, due before the bell. Analysts surveyed by FactSet expect a loss of 17 cents per share and quarterly revenue of $5.33 billion. Carnival stock rose 130% in 2023 as the industry recovered from Covid, but is down 8% so far this year, lagging its peers. — CNBC's Michelle Fox, Sarah Main and Jesse Pound contributed reporting.
Trending
- Tesla's Optimus Faces Human Competition at Robotics Conference in Beijing
- How to Position Yourself for a Global Tech Slowdown, According to Morgan Stanley
- Two big tests are coming that will determine whether last week's stock market excitement was justified.
- How a 'seriously outstanding tax debt' can lead to your passport being revoked
- Hezbollah fires rockets at Israel in revenge for its supreme leader
- Boeing Starliner Returns Empty, NASA Enlists SpaceX to Transport Astronauts
- Dividend Stocks Are a Hot Pick in the Fall Due to the Fed and Interest Rates
- Biden speaks with Zelensky, announces new military aid to Ukraine
HUD, GME, MRK and more
